Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-07

Clinical Trial Update: Efficacy and Safety of Sugammadex in Renal Diseased Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the efficacy and safety of sugammadex in patients with chronic kidney disease undergoing reversal of neuromuscular blockade; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sugammadex (sugammadex)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Kidney Failure, Chronic, Neuromuscular Blockade | Phase 4 | Status: COMPLETED